Cargando…

Gene Expression Changes Associated with Resistance to Intravenous Corticosteroid Therapy in Children with Severe Ulcerative Colitis

BACKGROUND AND AIMS: Microarray analysis of RNA expression allows gross examination of pathways operative in inflammation. We aimed to determine whether genes expressed in whole blood early following initiation of intravenous corticosteroid treatment can be associated with response. METHODS: From a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kabakchiev, Boyko, Turner, Dan, Hyams, Jeffrey, Mack, David, Leleiko, Neal, Crandall, Wallace, Markowitz, James, Otley, Anthony R., Xu, Wei, Hu, Pingzhao, Griffiths, Anne M., Silverberg, Mark S.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2948001/ https://www.ncbi.nlm.nih.gov/pubmed/20941359 http://dx.doi.org/10.1371/journal.pone.0013085

Ejemplares similares

Characterization of Stool Virome in Children Newly Diagnosed With Moderate to Severe Ulcerative Colitis
por: Tokarz, Rafal, et al.
Publicado: (2019)

Ulcerative Colitis Patients Continue to Improve Over the First Six Months of Vedolizumab Treatment: 12-Month Clinical and Mucosal Healing Effectiveness
por: Zezos, Petros, et al.
Publicado: (2020)

Ulcerative Colitis-Symptom Questionnaire: Valid for Use in Adults with Moderately to Severely Active Ulcerative Colitis
por: Panes, Julian, et al.
Publicado: (2023)

Long-Term Risk of Colectomy in Patients with Severe Ulcerative Colitis Responding to Intravenous Corticosteroids or Infliximab
por: De Cristofaro, Elena, et al.
Publicado: (2022)

Long-Term Outcomes and Predictive Factors of Hospitalized Patients with Severe Ulcerative Colitis Treated with Intravenous Corticosteroids
por: De Cristofaro, Elena, et al.
Publicado: (2021)

Factors associated with early outcomes following standardized therapy in children with ulcerative colitis (PROTECT): a multicentre inception cohort study
por: Hyams, Jeffrey S., et al.
Publicado: (2017)

Pharmacokinetics, Safety and Efficacy of Intravenous Vedolizumab in Paediatric Patients with Ulcerative Colitis or Crohn’s Disease: Results from the Phase 2 HUBBLE Study
por: Hyams, Jeffrey S, et al.
Publicado: (2022)

Twist1 contributes to developing and sustaining corticosteroid resistance in ulcerative colitis
por: Liu, Changqin, et al.
Publicado: (2021)

Combined effects of granulocyte and monocyte adsorption apheresis and corticosteroids on ulcerative colitis
por: Tsuzuki, Yoshikazu, et al.
Publicado: (2023)

Development and validation of novel models for the prediction of intravenous corticosteroid resistance in acute severe ulcerative colitis using logistic regression and machine learning
por: Yu, Si, et al.
Publicado: (2022)

Assessing disease activity using the pediatric Crohn’s disease activity index: Can we use subjective or objective parameters alone?
por: Grant, Amy, et al.
Publicado: (2021)

Ulcerative colitis mucosal transcriptomes reveal mitochondriopathy and personalized mechanisms underlying disease severity and treatment response
por: Haberman, Yael, et al.
Publicado: (2019)

Efficacy of Combined Mesalazine Plus Corticosteroid Enemas for Diversion Colitis after Subtotal Colectomy for Ulcerative Colitis
por: Matsumoto, Satohiro, et al.
Publicado: (2016)

Fatal rhinocerebral mucormycosis in a patient with ulcerative colitis receiving azathioprine and corticosteroid
por: Najafi, Narges, et al.
Publicado: (2019)

Analysis of the initial dose and reduction rate of corticosteroid for ulcerative colitis in clinical practice
por: Masuda, Masataka, et al.
Publicado: (2022)

Impact of Concomitant Corticosteroids on Tofacitinib Induction Efficacy and Infection Rates in Ulcerative Colitis
por: Lichtenstein, Gary R., et al.
Publicado: (2023)

Steroid-refractory ulcerative colitis treated with corticosteroids, metronidazole and vancomycin: a case report
por: Miner, Jonathan, et al.
Publicado: (2005)

A case of nocardiosis in a patient with ulcerative colitis on chronic corticosteroids, infliximab, and upadacitinib
por: Moy, Benjamin M., et al.
Publicado: (2023)

Fecal Calprotectin and Clinical Disease Activity in Pediatric Ulcerative Colitis
por: Kolho, Kaija-Leena, et al.
Publicado: (2013)

Predicting disease course in ulcerative colitis using stool proteins identified through an aptamer-based screen
por: Soomro, Sanam, et al.
Publicado: (2021)

Combination of corticosteroids and 5-aminosalicylates or corticosteroids alone for patients with moderate-severe active ulcerative colitis: A global survey of physicians' practice
por: Ben-Horin, Shomron, et al.
Publicado: (2017)

Safe administration of corticosteroids in severe ulcerative colitis and active SARS-CoV2 infection
por: Mayer, Pierre, et al.
Publicado: (2020)

Long-Term Benefit of Mesalamine Granules for Patients Who Achieved Corticosteroid-Induced Ulcerative Colitis Remission
por: Lichtenstein, Gary R., et al.
Publicado: (2015)

Use of corticosteroids for remission induction therapy in patients with new-onset ulcerative colitis in real-world settings
por: Okayasu, Motohiro, et al.
Publicado: (2019)

Therapeutic Efficacy of the Combination Therapy of Corticosteroids and 5-Aminosalicylic Acid for Treatment of Pyoderma Gangrenosum with Ulcerative Colitis
por: Chen, Wei, et al.
Publicado: (2020)

A Novel UC Exclusion Diet and Antibiotics for Treatment of Mild to Moderate Pediatric Ulcerative Colitis: A Prospective Open-Label Pilot Study
por: Sarbagili-Shabat, Chen, et al.
Publicado: (2021)

A154 COMPARING RESPONSE TO INTRAVENOUS IRON INFUSION IN CROHN’S DISEASE AND ULCERATIVE COLITIS
por: Su, S, et al.
Publicado: (2022)

Trends in Corticosteroid Prescriptions for Ulcerative Colitis and Factors Associated with Long-Term Corticosteroid Use: Analysis Using Japanese Claims Data from 2006 to 2016
por: Matsuoka, Katsuyoshi, et al.
Publicado: (2020)

ULCERATIVE COLITIS
Publicado: (1969)

Preoperative Corticosteroid Usage and Hypoalbuminemia Increase Occurrence of Short-term Postoperative Complications in Chinese Patients with Ulcerative Colitis
por: Li, Ji, et al.
Publicado: (2016)

Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitis
por: Chiorean, Michael V., et al.
Publicado: (2022)

Infliximab Induction Strategies in Corticosteroid-Refractory Acute Severe Ulcerative Colitis: A Case Series and Literature Review
por: Antunes, Pedro Bernardes, et al.
Publicado: (2022)

Factors Associated with Response to Systemic Corticosteroids in Active Ulcerative Colitis: Results from a Prospective, Multicenter Trial
por: Blesl, Andreas, et al.
Publicado: (2023)

Age-of-Diagnosis Dependent Ileal Immune Intensification and Reduced Alpha-Defensin in Older versus Younger Pediatric Crohn Disease Patients despite Already Established Dysbiosis
por: Haberman, Yael, et al.
Publicado: (2018)

Clinical Outcome Assessments in Pediatric Patients With Ulcerative Colitis and Crohn’s Disease Receiving Biologics: A Retrospective Cohort Study
por: Hunter, Theresa, et al.
Publicado: (2022)

Cost-effectiveness of intravenous vedolizumab vs subcutaneous adalimumab for moderately to severely active ulcerative colitis
por: Schultz, Bob G, et al.
Publicado: (2021)

Protein-Losing Enteropathy in Ulcerative Colitis
por: Ungaro, Ryan, et al.
Publicado: (2012)

Topical corticosteroid induced ulcerated striae()()
por: Verma, Shyam B., et al.
Publicado: (2021)

Infliximab versus Cyclosporine Treatment for Severe Corticosteroid-Refractory Ulcerative Colitis: A Korean, Retrospective, Single Center Study
por: Kim, Eun Hye, et al.
Publicado: (2015)

Corticosteroids Prior to Embryo Transfer in Assisted Reproduction in Women with Crohn’s Disease and Ulcerative Colitis – A Nationwide Cohort Study
por: Nørgård, Bente Mertz, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gd1jlceti8o6lesib559v8aaov